First Trust Nasdaq Pharmaceuticals ETF Rating $26.23 -0.06 (-0.23%) Closing price 03:59 AM EasternExtended Trading$26.23 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.59Holdings in FTXH have an aggregate rating of Moderate Buy based on 761 analyst ratings issued in the past year covering 50 companies (100.0% of the portfolio).FTXH Aggregate Price Target$26.22-0.06% DownsideHigh Prediction$26.22Average Prediction$26.22Low Prediction$26.22Holdings in FTXH have an aggregate price target of $26.22 and a range of $26.22 to $26.22 covering 50 companies (100.0% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold14 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.47%JNJJohnson & Johnson$156.19+0.6%4.9447 of 5 stars2.55$170.88 9.4%20Trending News7.22%ABBVAbbVie$192.58+0.6%4.9131 of 5 stars2.81$211.29 9.7%27Trending NewsAnalyst ForecastAnalyst Revision7.02%PFEPfizer$24.69+0.9%4.9799 of 5 stars2.53$29.17 18.1%15Trending NewsAnalyst Revision6.80%MRKMerck & Co., Inc.$80.61+0.4%4.9978 of 5 stars2.43$109.19 35.5%21Positive NewsAnalyst Revision6.45%BMYBristol-Myers Squibb$50.35+0.4%4.7868 of 5 stars2.32$58.00 15.2%22Positive NewsAnalyst Revision4.05%UTHRUnited Therapeutics$277.57-1.3%4.9943 of 5 stars2.69$393.08 41.6%13Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume4.04%ZTSZoetis$165.76-0.3%4.6001 of 5 stars3.10$212.75 28.3%10Positive News3.91%GILDGilead Sciences$110.19+0.8%4.8729 of 5 stars2.78$110.55 0.3%27Trending NewsAnalyst Revision3.77%BIIBBiogen$132.80-0.2%4.7617 of 5 stars2.38$191.30 44.0%32Positive NewsAnalyst Forecast3.75%AMGNAmgen$293.50+0.6%4.4659 of 5 stars2.38$309.22 5.4%24Positive NewsAnalyst Revision3.75%VTRSViatris$8.96-0.2%2.5528 of 5 stars1.80$10.40 16.1%53.32%LLYEli Lilly and Company$811.97+0.4%4.9878 of 5 stars2.76$1,011.37 24.6%21Trending NewsAnalyst Revision3.08%JAZZJazz Pharmaceuticals$110.28-0.2%4.9677 of 5 stars2.92$184.00 66.8%13Analyst Forecast2.80%REGNRegeneron Pharmaceuticals$517.17-0.3%4.8937 of 5 stars2.85$836.48 61.7%26Analyst ForecastAnalyst Revision2.34%EXELExelixis$41.90+1.1%4.4724 of 5 stars2.47$39.35 -6.1%19Positive NewsAnalyst Forecast2.26%ELANElanco Animal Health$14.13-1.0%1.0764 of 5 stars2.43$15.17 7.3%7Positive News2.00%CRLCharles River Laboratories International$149.34-1.2%4.735 of 5 stars2.18$171.85 15.1%171.84%OGNOrganon & Co.$10.04-0.4%4.8019 of 5 stars2.50$18.00 79.3%6Trending News1.79%MEDPMedpace$301.17-0.4%4.6834 of 5 stars2.23$349.30 16.0%13Positive News1.72%ILMNIllumina$87.14-0.5%4.8988 of 5 stars2.47$126.94 45.7%19Positive NewsAnalyst ForecastOptions Volume1.58%NBIXNeurocrine Biosciences$123.68-0.9%4.8952 of 5 stars2.86$162.00 31.0%22Analyst Revision1.37%HALOHalozyme Therapeutics$54.17+0.6%4.9167 of 5 stars2.17$61.90 14.3%12Positive News1.12%ALKSAlkermes$31.22+0.1%4.3036 of 5 stars2.77$38.85 24.4%13Insider Trade1.11%BMRNBioMarin Pharmaceutical$57.12-0.6%4.949 of 5 stars2.74$93.45 63.6%23Positive NewsAnalyst Revision0.94%PRGOPerrigo$27.15-0.8%4.6162 of 5 stars2.25$33.00 21.5%40.84%CPRXCatalyst Pharmaceuticals$25.02-1.5%4.74 of 5 stars3.25$32.83 31.2%80.83%PBHPrestige Consumer Healthcare$85.18+0.1%3.6524 of 5 stars2.50$93.33 9.6%6Positive News0.81%AMRXAmneal Pharmaceuticals$7.87+1.2%3.731 of 5 stars3.00$11.60 47.3%50.73%BPMCBlueprint Medicines$127.951.1972 of 5 stars2.32$129.35 1.1%220.73%TGTXTG Therapeutics$38.10-0.6%2.9516 of 5 stars2.80$40.80 7.1%5Positive NewsAnalyst Revision0.69%ADMAADMA Biologics$21.96+0.4%2.1842 of 5 stars3.25$24.25 10.4%4Insider TradeAnalyst Revision0.67%ALNYAlnylam Pharmaceuticals$299.70+0.4%4.288 of 5 stars2.77$319.17 6.5%26Positive News0.65%CAHCardinal Health$154.73+0.8%4.5212 of 5 stars2.79$150.57 -2.7%14Positive NewsAnalyst Forecast0.63%CORTCorcept Therapeutics$71.06-1.7%4.615 of 5 stars3.00$138.25 94.5%5Positive News0.63%EXASExact Sciences$55.50-0.3%4.5978 of 5 stars2.95$70.90 27.7%22Positive News0.62%GHGuardant Health$48.74-0.6%3.797 of 5 stars3.05$53.29 9.3%21Insider Trade0.61%AKROAkero Therapeutics$52.19-1.5%3.6396 of 5 stars3.00$82.50 58.1%7Insider TradeOptions Volume0.61%ACADACADIA Pharmaceuticals$22.04-0.7%3.2663 of 5 stars2.69$26.79 21.6%16Trending NewsAnalyst Revision0.52%PTCTPTC Therapeutics$51.10+0.6%4.3445 of 5 stars2.64$63.75 24.8%14Analyst Revision0.51%VRTXVertex Pharmaceuticals$453.56+0.2%4.6474 of 5 stars2.57$515.04 13.6%30Positive NewsAnalyst Revision0.51%INCYIncyte$68.81-0.1%4.4912 of 5 stars2.17$72.53 5.4%18Positive News0.49%INSMInsmed$98.66+0.7%3.4872 of 5 stars3.00$104.81 6.2%18Trending NewsAnalyst ForecastAnalyst Revision0.48%AXSMAxsome Therapeutics$108.50+0.4%4.6999 of 5 stars3.06$172.80 59.3%16Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.48%SRRKScholar Rock$33.51-2.7%4.4642 of 5 stars3.14$42.67 27.3%7Positive News0.46%VCELVericel$44.25-3.2%2.6777 of 5 stars3.00$61.14 38.2%7Positive News0.45%MDGLMadrigal Pharmaceuticals$293.87+4.1%4.3511 of 5 stars2.89$420.63 43.1%9Positive NewsAnalyst Revision0.44%SWTXSpringWorks Therapeutics$46.76+0.0%1.597 of 5 stars2.13$52.57 12.4%8Positive News0.43%VCYTVeracyte$27.92+0.1%4.0088 of 5 stars2.70$40.90 46.5%100.42%KRYSKrystal Biotech$138.19-1.0%4.689 of 5 stars3.00$211.13 52.8%9Positive NewsAnalyst Revision0.22%SRPTSarepta Therapeutics$37.56-0.7%4.8283 of 5 stars2.87$122.61 226.4%23Positive News This page (NASDAQ:FTXH) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored2025 Market Crash50-Year Legend: Here's The Day Stocks Likely Crash Investing legend finds best cycle indicator during 50-ye...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FTXH Stock Free FTXH Stock Alerts